| Model Number |
N/A |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
07/04/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Siemens requested a list of medications that the patient is receiving and also asked if the sample is available for testing.The information and the sample are not available.Root cause of the difference in results between the advia centaur afp and the alternate method with this one sample cannot be determined.The warning in the intended use section of the advia centaur afp instruction for use states: "the concentration of afp in a given specimen, as determined by assays from different manufacturers, can vary due to differences in assay methods and reagent specificity.The results reported by the laboratory to the physician must include the identity of the afp assay used.Values obtained with different afp assay methods cannot be used interchangeably." additionally, the warning in the intended use section of the advia centaur afp instruction for use states: "use afp results only as part of the overall clinical evaluation of a patient.Do not use afp results as the only criterion for diagnosis." based on the available information advia centaur afp is performing as intended.
|
| |
|
Event or Problem Description
|
|
Customer observed an elevated advia centaur xp alpha-fetoprotein (afp) result compared to an alternate method and the clinical picture.There are no reports that treatment was altered or prescribed or adverse health consequences due to the elevated advia centaur xp afp result.
|
| |
|
Search Alerts/Recalls
|